The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 348:264-265 January 16, 2003 Number 3
NextNext

Nephrolithiasis, Osteoporosis, and Mutations in the Type 2a Sodium–Phosphate Cotransporter

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Prié, D.
-PubMed Citation
To the Editor: In the report by Prié et al. (Sept. 26 issue)1 indicating that inactivating mutations in the sodium–phosphate cotransporter gene, NPT2a, are associated with renal phosphate wasting and bone demineralization, the data on expression do not support a dominant negative effect of the V147M mutation. As the authors themselves acknowledge, coinjection of 10 ng of wild-type RNA and 10 ng of mutant (V147M) RNA yielded a phosphate-induced current "similar to that in oocytes expressing 10 ng of wild-type NPT2a RNA alone." The comparison of this current with that produced by injection of 20 ng of wild-type RNA is . . . [Full Text of this Article]


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.